Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new alphagan clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on alphagan
- Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Recruiting, Condition Summary: Retina; Ocular Physiology - Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%
Status: Recruiting, Condition Summary: Erythematous Rosacea - Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
Status: Recruiting, Condition Summary: Ocular Hypertension; Open-Angle Glaucoma - Brimonidine vs Placebo on Intraocular Pressure During Spine Surgery
Status: Recruiting, Condition Summary: Intra-Ocular Pressure; Prone Spinal Surgery - Safety and Effects of Brimonidine Intravitreal Implant in Patients With Primary Open-Angle Glaucoma
Status: Not yet recruiting, Condition Summary: Glaucoma - Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
Status: Completed, Condition Summary: Primary Open Angle Glaucoma; Ocular Hypertension - 24-Hour IOP-Lowering Effect of Brimonidine 0.1%
Status: Recruiting, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa
Status: Not yet recruiting, Condition Summary: Retinitis Pigmentosa - Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-Related Macular Degeneration (AMD)
Status: Not yet recruiting, Condition Summary: Macular Degeneration - Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Glaucoma; Ocular Hypertension - Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Glaucoma; Ocular Hypertension - Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
Status: Completed, Condition Summary: Glaucoma; Ocular Hypertension - Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Glaucoma; Ocular Hypertension - A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt
Status: Recruiting, Condition Summary: Open Angle Glaucoma; Ocular Hypertension - Study to Determine if Taking an Over The Counter Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Eye Drops for the Treatment of Glaucoma
Status: Completed, Condition Summary: Glaucoma; Ocular Hypertension - Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%
Status: Completed, Condition Summary: Glaucoma; Ocular Hypertension - Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
Status: Recruiting, Condition Summary: Glaucoma; Ocular Hypertension - Absorption of Brimonidine Ophthalmic Solution in the Aqueous Humor of Cataract Patients
Status: Completed, Condition Summary: Cataract - Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
Status: Completed, Condition Summary: Glaucoma - Brimonidine vs ALTP in Progressing Human Glaucoma
Status: Completed, Condition Summary: Glaucoma - Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
Status: Active, not recruiting, Condition Summary: Glaucoma - Visual Function Changes After Intraocular Pressure Reduction
Status: Completed, Condition Summary: Glaucoma - Effects of Topical Clonidine vs. Brimonidine on Choroidal Blood Flow and Intraocular Pressure During Isometric Exercise
Status: Completed, Condition Summary: Ocular Physiology; Regional Blood Flow - Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
Status: Completed, Condition Summary: Healthy - INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE
Status: Terminated, Condition Summary: Glaucoma - A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Open-Angle Glaucoma; Ocular Hypertension - Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Ocular Hypertension - Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Ocular Hypertension - Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Status: Completed, Condition Summary: Ocular Hypertension - Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma
Status: Completed, Condition Summary: Glaucoma, Open Angle
